Skip to main content
Erschienen in: Journal of Cancer Research and Clinical Oncology 7/2019

21.05.2019 | Original Article – Cancer Research

Growth patterns of small peripheral squamous cell carcinoma of the lung and their impacts on pathological and biological characteristics of tumor cells

verfasst von: Tomokazu Omori, Keiju Aokage, Hiroshi Nakamura, Shinya Katsumata, Tomohiro Miyoshi, Masato Sugano, Motohiro Kojima, Satoshi Fujii, Takeshi Kuwata, Atsushi Ochiai, Norihiko Ikeda, Masahiro Tsuboi, Genichiro Ishii

Erschienen in: Journal of Cancer Research and Clinical Oncology | Ausgabe 7/2019

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The growth pattern of peripheral squamous cell carcinoma (SCC) of the lung is divided into two types: alveolar space-filling (ASF) growth and alveolar space-destructive (ASD) growth. The aim of this study was to investigate the clinicopathological differences between cancer cells displaying ASF and ASD growth.

Methods

We analyzed 155 patients with peripheral SCC measuring 30 mm or less in diameter. The proportion of ASF in the total tumor area (%ASF) was determined using digital image analysis. We examined the clinicopathological characteristics of the cancer cells and compared the immunophenotypes of high %ASF tumors (> 30%) and low %ASF tumors (0%). Finally, we analyzed the prognostic impact of ASD area with small SCC cases (≤ 2.0 cm, n = 72).

Results

Cases of high %ASF tumors showed significantly lower frequencies of lymphovascular invasion (p = 0.008). Immunohistochemical staining revealed that the expression score of laminin-5, invasive-related molecule, in cancer cells was significantly lower in high %ASF cases than in low %ASF cases (p = 0.001). Within the same tumor, laminin-5 expression in the ASF area was significantly lower than that in the ASD area (p = 0.001). The overall 5-year survival rate of patients with a larger ASD area (> 1.0 cm2) was significantly lower than that of patients with a smaller ASD area (≤ 1.0 cm2) (p = 0.017).

Conclusions

In this study, we clearly showed that cancer cells presenting with ASF represents a “less invasive phenotype” in peripheral SCC.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
Zurück zum Zitat Carter D (1985) Squamous cell carcinoma of the lung: an update. Semin Diagn Pathol 2:226–234PubMed Carter D (1985) Squamous cell carcinoma of the lung: an update. Semin Diagn Pathol 2:226–234PubMed
Zurück zum Zitat Dingemans KP, Mooi WJ (1984) Ultrastructure of squamous cell carcinoma of the lung. Pathol Annu 19(Pt 1):249–273PubMed Dingemans KP, Mooi WJ (1984) Ultrastructure of squamous cell carcinoma of the lung. Pathol Annu 19(Pt 1):249–273PubMed
Zurück zum Zitat Funai K, Yokose T, Ishii G et al (2003) Clinicopathologic characteristics of peripheral squamous cell carcinoma of the lung. Am J Surg Pathol 27:978–984CrossRefPubMed Funai K, Yokose T, Ishii G et al (2003) Clinicopathologic characteristics of peripheral squamous cell carcinoma of the lung. Am J Surg Pathol 27:978–984CrossRefPubMed
Zurück zum Zitat Huhti E, Saloheimo M, Sutinen S et al (1983) Does the location of lung cancer affect its prognosis? Eur J Respir Dis 64:460–465PubMed Huhti E, Saloheimo M, Sutinen S et al (1983) Does the location of lung cancer affect its prognosis? Eur J Respir Dis 64:460–465PubMed
Zurück zum Zitat Kawabata Y, Sakamoto S, Umino T et al (1996) Growth of squamous cells lung cancer between alveolar basement membrane and alveolar epithelium. Nihon Kyobu Shikkan Gakkai Zasshi 34:878–884PubMed Kawabata Y, Sakamoto S, Umino T et al (1996) Growth of squamous cells lung cancer between alveolar basement membrane and alveolar epithelium. Nihon Kyobu Shikkan Gakkai Zasshi 34:878–884PubMed
Zurück zum Zitat Malara NM, Sgambato A, Granone P et al (1999) Biological characterization of central and peripheral primary non small cell lung cancers (NSCLC). Anticancer Res 19:2249–2252PubMed Malara NM, Sgambato A, Granone P et al (1999) Biological characterization of central and peripheral primary non small cell lung cancers (NSCLC). Anticancer Res 19:2249–2252PubMed
Zurück zum Zitat Mizushima Y, Yamashita R, Kusajima Y et al (2000) Prognostic comparison between peripheral and central types of squamous cell carcinoma of the lung in patients undergoing surgical resection. Oncol Rep 7:319–322PubMed Mizushima Y, Yamashita R, Kusajima Y et al (2000) Prognostic comparison between peripheral and central types of squamous cell carcinoma of the lung in patients undergoing surgical resection. Oncol Rep 7:319–322PubMed
Zurück zum Zitat Moriya Y, Niki T, Yamada T et al (2001) Increased expression of laminin-5 and its prognostic significance in lung adenocarcinomas of small size. An immunohistochemical analysis of 102 cases. Cancer 91:1129–1141CrossRefPubMed Moriya Y, Niki T, Yamada T et al (2001) Increased expression of laminin-5 and its prognostic significance in lung adenocarcinomas of small size. An immunohistochemical analysis of 102 cases. Cancer 91:1129–1141CrossRefPubMed
Zurück zum Zitat Paakko P, Risteli J, Risteli L, Autio-Harmainen H (1990) Immunohistochemical evidence that lung carcinomas grow on alveolar basement membranes. Am J Surg Pathol 14:464–473CrossRefPubMed Paakko P, Risteli J, Risteli L, Autio-Harmainen H (1990) Immunohistochemical evidence that lung carcinomas grow on alveolar basement membranes. Am J Surg Pathol 14:464–473CrossRefPubMed
Zurück zum Zitat ten Velde GP, Havenith MG, Volovics A et al (1991) Prognostic significance of basement membrane deposition in operable squamous cell carcinomas of the lung. Cancer 67:3001–3005CrossRefPubMed ten Velde GP, Havenith MG, Volovics A et al (1991) Prognostic significance of basement membrane deposition in operable squamous cell carcinomas of the lung. Cancer 67:3001–3005CrossRefPubMed
Zurück zum Zitat Tomashefski JF Jr, Connors AF Jr, Rosenthal ES et al (1990) Peripheral vs central squamous cell carcinoma of the lung. A comparison of clinical features, histopathology, and survival. Arch Pathol Lab Med 114:468–474PubMed Tomashefski JF Jr, Connors AF Jr, Rosenthal ES et al (1990) Peripheral vs central squamous cell carcinoma of the lung. A comparison of clinical features, histopathology, and survival. Arch Pathol Lab Med 114:468–474PubMed
Zurück zum Zitat Udagawa H, Ishii G, Morise M et al (2015) Comparison of the expression levels of molecular markers among the peripheral area and central area of primary tumor and metastatic lymph node tumor in patients with squamous cell carcinoma of the lung. J Cancer Res Clin Oncol 141:1417–1425. https://doi.org/10.1007/s00432-015-1912-7 CrossRefPubMed Udagawa H, Ishii G, Morise M et al (2015) Comparison of the expression levels of molecular markers among the peripheral area and central area of primary tumor and metastatic lymph node tumor in patients with squamous cell carcinoma of the lung. J Cancer Res Clin Oncol 141:1417–1425. https://​doi.​org/​10.​1007/​s00432-015-1912-7 CrossRefPubMed
Metadaten
Titel
Growth patterns of small peripheral squamous cell carcinoma of the lung and their impacts on pathological and biological characteristics of tumor cells
verfasst von
Tomokazu Omori
Keiju Aokage
Hiroshi Nakamura
Shinya Katsumata
Tomohiro Miyoshi
Masato Sugano
Motohiro Kojima
Satoshi Fujii
Takeshi Kuwata
Atsushi Ochiai
Norihiko Ikeda
Masahiro Tsuboi
Genichiro Ishii
Publikationsdatum
21.05.2019
Verlag
Springer Berlin Heidelberg
Erschienen in
Journal of Cancer Research and Clinical Oncology / Ausgabe 7/2019
Print ISSN: 0171-5216
Elektronische ISSN: 1432-1335
DOI
https://doi.org/10.1007/s00432-019-02937-9

Weitere Artikel der Ausgabe 7/2019

Journal of Cancer Research and Clinical Oncology 7/2019 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.